Our Scientific Advisory Board

Comprising internationally renowned researchers and physician-scientists in oncology, often leaders of major foreign research institutions, the Scientific Advisory Board supports the institute in its choices. It is chaired by Prof. Edith Heard.
Le conseil scientifique

The Scientific Advisory Board takes part in strategic research decisions and in the initiatives taken or planned. Each year, this organization issues its recommendations to the Executive Board.


  • Prof. Edith Heard

Chairman of the Scientific Advisory Board

Director General, European Molecular Biology Laboratory (EMBL) – Heidelberg (Germany)

Professor at Collège de France


  • Prof. Alain FISCHER

Vice-Chairman of the Scientific Advisory Board

Director of the Research Institute of Genetic Diseases (Imagine), Hospital Necker-Enfants Malades, Université Paris Descartes, UMR INSERM 1163, Professor at Collège de France, Chair of « Médecine expérimentale » – Paris (France)

  • Pr Anton BERNS

Senior Staff Member, Division of Molecular Genetics The Netherlands Cancer Institute – Amsterdam (The Netherlands)

  • Pr Robert BRISTOW

Manchester University, Professor of Cancer Studies, Director of Manchester Cancer Research Center – Manchester (United Kingdom)

  • Pr Pascale COSSART

Professor at Institut Pasteur, Head of the Bacteria-Cell Interactions Unit (Inserm U604 / INRA USC2020) – Paris (France)

  • Pr Eileen E.M. FURLONG

Head of the Genome Biology Unit, Senior Scientist and European Molecular Biology Laboratory (EMBL) – Heidelberg (Germany)

  • Dr Luca GIANNI, MD

Chair Breast Cancer Committee

Michelangelo Foundation – Milan (Italy)


Director at the Max Planck Institute for Medical Research, Department of Chemical Biology – Heidelberg (Germany)

  • Pr Daniel LOUVARD

Honorary Director of Institut Curie Research Center Institut Curie – Paris (France)

  • Pre Miriam MERAD

Director of the Precision Immunology Institute at Mount Sinai School of Medicine, Director of the Mount Sinai Human Immune Monitoring Center (HIMC) – New York (United States)

  • Pr Angela NIETO 

CSIC Fill Professor Instituto de Neurociencias (CSIC-UMH) – San Juan de Alicante (Spain)

  • Pr Paul NURSE

Director of the Francis Crick Institute – London (United Kingdom)

  • Pre Martine PICCART

Professor in Oncology at the Université Libre de Bruxelles and Head of the Department of Medicine at the Jules Bordet Institute – Brussels (Belgium)


Professor of Cell Biology within the Schools of Basic & Medical Biosciences and Cancer & Pharmaceuticals Sciences, King’s College – London (United Kingdom)

  • Pr Charlie SWANTON FRCP, PhD, FMedSci, FAACR, FRS

The Francis Crick Institute – London (United Kingdom)


Professor of Pathology, Head of the Pathology Department, Academic Medical Center – Amsterdam (The Netherlands